Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens

References

• Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. Can Med Assoc J. 2010;182(4):349–355.
   Web of Science ®Google Scholar
• Kao K-C, Chang K-W, Chan M-C, et al.; TSIRC (Taiwan Severe Influenza Research Consortium). Predictors of survival in patients with influenza pneumonia-related severe acute respiratory distress syndrome treated with prone positioning. Ann Intensive Care. 2018;8:94.
   PubMed Web of Science ®Google Scholar
• Fartoukh M, Voiriot G, Guérin L, et al. Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot study. Ann Intensive Care. 2021;11:117.
   PubMed Web of Science ®Google Scholar
• Taylor G, Abdesselam K, Pelude L, et al. Epidemiological features of influenza in Canadian adult intensive care unit patients. Epidemiol Infect. 2016;144:741–750.
   PubMed Web of Science ®Google Scholar
• Hussain M, Nasir N, Irfan M, et al. Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, Pakistan. Pneumonia. 2020;12:5.
   Web of Science ®Google Scholar
• Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–970.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, van Someren Gréve F, Schultz MJ. Bacterial pneumonia as an influenza complication. Curr Opin Infect Dis. 2017;30:201–207.
   PubMed Web of Science ®Google Scholar
• McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252–262.
   PubMed Web of Science ®Google Scholar
• Rouze A, Martin-Loeches I, Povoa P, et al. Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: a European multicenter comparative cohort study. Am J Respir Crit Care Med 2021;204:546–556.
   PubMed Web of Science ®Google Scholar
• Chastre J, Fagon J-Y. Ventilator-associated Pneumonia Am J Respir Crit Care Med . 2002;165:37.
   Web of Science ®Google Scholar
• Martin-Loeches I, Schultz J, Vincent M, et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43:48–58.
   PubMed Web of Science ®Google Scholar
• Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) Virus. Chest. 2011;139:555–562.
   PubMed Web of Science ®Google Scholar
• Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States*. Crit Care Med. 2012;40:1487–1498.
   PubMed Web of Science ®Google Scholar
• Rozencwajg S, Guihot A, Franchineau G, et al. Ultra-protective ventilation reduces biotrauma in patients on venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome*. Crit Care Med. 2019;47:1505–1512.
   PubMed Web of Science ®Google Scholar
• Jacquot A, Luyt C-E, Kimmoun A, et al., The Fluvalentine Study group. Epidemiology of post-influenza bacterial pneumonia due to Panton–Valentine leucocidin positive Staphylococcus aureus in intensive care units: a retrospective nationwide study. Intensive Care Med. 2019;45:1312–1314.
   PubMed Web of Science ®Google Scholar
• Niemann S, Ehrhardt C, Medina E, et al. Combined action of influenza virus and staphylococcus aureus panton–valentine leukocidin provokes severe lung epithelium damage. J Infect Dis. 2012;206:1138–1148.
   PubMed Web of Science ®Google Scholar
• Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by staphylococcus aureus containing panton-valentine leukocidin. Clin Infect Dis. 2007;45:315–321.
   PubMed Web of Science ®Google Scholar
• Rodríguez AH, Avilés-Jurado FX, Díaz E, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect. 2016;72:143–151.
   PubMed Web of Science ®Google Scholar
• Cuquemelle E, Soulis F, Villers D, et al.; A/H1N1 REVA-SRLF Study Group. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med. 2011;37:796–800.
   PubMed Web of Science ®Google Scholar
• Pfister R, Kochanek M, Leygeber T, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care. 2014;18:R44.
   PubMed Web of Science ®Google Scholar
• Carbonell R, Moreno G, Martín-Loeches I, et al. Prognostic value of procalcitonin and c-reactive protein in 1608 critically ill patients with severe influenza pneumonia Antibiotics (Basel). 2021(350) :11.
   Google Scholar
• Gautam S, Cohen AJ, Stahl Y, et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia. Thorax. 2020;75:974–981.
   PubMed Web of Science ®Google Scholar
• Dumitrescu O, Badiou C, Bes M, et al. Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect. 2008;14:384–388.
   PubMed Web of Science ®Google Scholar
• Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–759.
   PubMed Web of Science ®Google Scholar
• Curcio D, Ferreira Cabrera L, Duarte A, et al. Ventilator-associated pneumonia in patients with 2009 pandemic influenza a (h1n1) infection: an observational study. J Chemother. 2010;22:428–430.
   PubMed Web of Science ®Google Scholar
• H1N1 Registry Contributors TESICM, Martin-Loeches I, Lisboa T, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011;37:272–283.
   PubMed Web of Science ®Google Scholar
• Nseir S, Martin-Loeches I, Povoa P, et al. Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021;25:177.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Rijnders BJA, Brüggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524–1535.
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64.
   Google Scholar
• Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–792.
   PubMed Web of Science ®Google Scholar
• Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38:1761–1768.
   PubMed Web of Science ®Google Scholar
• Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39:1915–1923.
   PubMed Web of Science ®Google Scholar
• Y-H K, Chan K-S, Yang -C-C, et al. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections. J Formos Med Assoc. 2017;116:660–670.
   PubMed Web of Science ®Google Scholar
• Ullmann AJ, Langston A, Reddy V. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007 356 ;335–347.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Perfect J, Helfgott D, et al. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia. N Engl J Med 2007;356:348–359.
   PubMed Web of Science ®Google Scholar
• Cantan B, Luyt C-E, Martin-Loeches I. Influenza infections and emergent viral infections in intensive care unit. Semin Respir Crit Care Med. 2019;40:488–497.
   PubMed Web of Science ®Google Scholar
• Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385:1729–1737.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Diaz E, Martin-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66:1140–1149.
   PubMed Web of Science ®Google Scholar
• Muthuri SG, Venkatesan S, Myles PR, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses. 2016;10:192–204.
   PubMed Web of Science ®Google Scholar
• Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. Can Med Assoc J. 2010;182:357–363.
   PubMed Web of Science ®Google Scholar
• South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013;346:f3039–f3039.
   PubMed Web of Science ®Google Scholar
• Lemaitre F, Luyt C-E, Roullet-Renoleau F, et al. Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation. Intensive Care Med. 2010;36:1273–1274.
   PubMed Web of Science ®Google Scholar
• Leung YH, Lim WL, Wong MH, et al. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect. 2012;140:814–817.
   PubMed Web of Science ®Google Scholar
• Kkw T, Hung IFN, Iws L, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50:850–859.
   PubMed Web of Science ®Google Scholar
• Behillil S, May F, Fourati S, et al. Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study. Clin Infect Dis. 2020;71:1089–1091.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Trujillo AA, Sheu TG, et al. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Antiviral Res. 2012;93:381–386.
   PubMed Web of Science ®Google Scholar
• Liu J-W, Lin S-H, Wang L-C, et al. Comparison of antiviral agents for seasonal influenza outcomes in healthy adults and children: a systematic review and network meta-analysis. JAMA Network Open. 2021;4:e2119151.
   PubMed Web of Science ®Google Scholar
• Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017;5:135–146.
   PubMed Web of Science ®Google Scholar
• Lee JS, Lee MS, Park Y, et al. Clinical effectiveness of intravenous peramivir versus oseltamivir for the treatment of influenza in hospitalized patients. Infect Drug Resist. 2020;13:1479–1484.
   PubMed Web of Science ®Google Scholar
• Luyt C-E, Hékimian G, Bréchot N, et al. Viral ventilator-associated pneumonia/hospital-acquired pneumonia. Semin Respir Crit Care Med. 2022;43. DOI:10.1055/s-0041-1740981
   Web of Science ®Google Scholar
• Luyt C-E, Bréchot N, Chastre J. What role do viruses play in nosocomial pneumonia? Curr Opin Infect Dis. 2014;27:194–199.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Coopersmith CM, McDunn JE, et al. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15:496–497.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260–268.
   PubMed Web of Science ®Google Scholar
• Luyt C-E, Combes A, Deback C, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med. 2007;175:935–942.
   PubMed Web of Science ®Google Scholar
• Bruynseels P, Jorens PG, Demey HE, et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet. 2003;362:1536–1541.
   PubMed Web of Science ®Google Scholar
• Ong GM, Lowry K, Mahajan S, et al. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol. 2004;72:121–125.
   PubMed Web of Science ®Google Scholar
• Linssen CFM, Jacobs JA, Stelma FF, et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med. 2008;34:2202.
   PubMed Web of Science ®Google Scholar
• Costa C, Sidoti F, Saldan A, et al. Clinical impact of HSV-1 detection in the lower respiratory tract from hospitalized adult patients. Clin Microbiol Infect. 2012;18:E305–7.
   PubMed Web of Science ®Google Scholar
• Gooskens J, Templeton KE, Claas EC, et al. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract. J Med Virol. 2007;79:597–604.
   PubMed Web of Science ®Google Scholar
• Tuxen DV, Cade JF, McDonald MI, et al. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis. 1982;4 416–419/126 .
   Google Scholar
• Hraiech S, Azoulay E, Papazian L. Herpesviruses in critically Ill patients with ARDS Encycl Respir Med. Encycl. Respir. Med. 2022;n.d.: 373–385.
   Google Scholar
• Graham BS, Snell JD. Herpes simplex virus infection of the adult lower respiratory tract. Medicine (Baltimore). 1983;62:384–394.
   PubMed Web of Science ®Google Scholar
• De Vos N, Van Hoovels L, Vankeerberghen A, et al. Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study. Clin Microbiol Infect. 2009;15:358–363.
   PubMed Web of Science ®Google Scholar
• Deback C, Luyt CE, Lespinats S, et al. Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation. J Clin Virol. 2010;47:313–320.
   PubMed Web of Science ®Google Scholar
• Nath P, Kabir MA, Doust SK, et al. Diagnosis of herpes simplex virus: laboratory and point-of-care techniques. Infect Dis Rep. 2021;13:518–539.
   PubMed Web of Science ®Google Scholar
• Smith CA, Conroy LT, Pollock M, et al. Detection of herpes viruses in respiratory secretions of patients undergoing artificial ventilation. J Med Virol. 2010;82:1406–1409.
   PubMed Web of Science ®Google Scholar
• Daubin C, Vincent S, Vabret A, et al. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med. 2005;31:1116–1122.
   PubMed Web of Science ®Google Scholar
• Luyt C-E. Virus diseases in ICU patients: a long time underestimated; but be aware of overestimation. Intensive Care Med. 2006;32:968–970.
   PubMed Web of Science ®Google Scholar
• Chong S, Kim TS, Cho EY. Herpes simplex virus pneumonia: high-resolution CT findings. Br J Radiol. 2010;83:585–589.
   PubMed Web of Science ®Google Scholar
• Aquino SL, Dunagan DP, Chiles C, et al. Herpes simplex virus 1 pneumonia: patterns on CT scans and conventional chest radiographs. J Comput Assist Tomogr. 1998;22:795–800.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Di Bella S, Lovecchio A, et al. Herpes simplex virus 1 (HSV-1) reactivation in critically Ill COVID-19 patients: a brief narrative review. Infect Dis Ther. 2022. 10.1007/s40121-022-00674-0.
   Web of Science ®Google Scholar
• Meyer A, Buetti N, Houhou-Fidouh N, et al. HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients. Crit Care. 2021;25:417.
   PubMed Web of Science ®Google Scholar
• Bouza E, Giannella M, Torres MV, et al. Herpes simplex virus: a marker of severity in bacterial ventilator-associated pneumonia. J Crit Care. 2011;26:432.e1–432.e6.
   PubMed Web of Science ®Google Scholar
• Scheithauer S, Manemann AK, Krüger S, et al. Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection. 2010;38:401–405.
   PubMed Web of Science ®Google Scholar
• Coisel Y, Bousbia S, Forel J-M, et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS ONE. 2012;7:e51340.
   PubMed Web of Science ®Google Scholar
• López-Giraldo A. Viral-reactivated pneumonia during mechanical ventilation: is there need for antiviral treatment? Front Pharmacol. 2011;2. .
   PubMed Web of Science ®Google Scholar
• Ryan L, Heed A, Foster J, et al. Acute kidney injury (AKI) associated with intravenous acyclovir in adults: incidence and risk factors in clinical practice. Int J Infect Dis. 2018;74:97–99.
   PubMed Web of Science ®Google Scholar
• Tuxen DV, Wilson JW, Cade JF. prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1987;136:402–405.
   PubMedGoogle Scholar
• Traen S, Bochanen N, Ieven M, et al. Is Acyclovir effective among critically ill patients with herpes simplex in the respiratory tract? J Clin Virol. 2014;60:215–221.
   PubMed Web of Science ®Google Scholar
• van den Brink J-W, Simoons-Smit AM, Beishuizen A, et al. Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill: marker or mediator? J Clin Virol. 2004;30:68–72.
   PubMed Web of Science ®Google Scholar
• Schuierer L, Gebhard M, Ruf H-G, et al. Impact of Acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication. Crit Care. 2020;24:12.
   PubMed Web of Science ®Google Scholar
• Heimes E, Baier M, Forstner C, et al. Effect of antiviral therapy on the outcome of mechanically ventilated patients with herpes simplex virus type 1 in BAL fluid. Chest. 2020;158:1867–1875.
   PubMed Web of Science ®Google Scholar
• Hagel S, Scherag A, Schuierer L, et al. Effect of antiviral therapy on the outcomes of mechanically ventilated patients with herpes simplex virus detected in the respiratory tract: a systematic review and meta-analysis. Crit Care. 2020;24:584.
   PubMed Web of Science ®Google Scholar
• Luyt C-E, Forel J-M, Hajage D, et al. Acyclovir for mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: a randomized clinical trial. JAMA Intern Med. 2020;180:263.
   PubMed Web of Science ®Google Scholar
• Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically Ill immunocompetent JAMA 2008 300 413–422 . Patients n.d.:10.
   PubMed Web of Science ®Google Scholar
• Chiche L, Forel J-M, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients*. Crit Care Med. 2009;37:1850–1857.
   PubMed Web of Science ®Google Scholar
• Li X, Huang Y, Xu Z, et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis. 2018;18:289.
   PubMed Web of Science ®Google Scholar
• Papazian L, Hraiech S, Lehingue S, et al. Cytomegalovirus reactivation in ICU patients. Intensive Care Med. 2016;42:28–37.
   PubMed Web of Science ®Google Scholar
• Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13:R68.
   PubMed Web of Science ®Google Scholar
• Al-Omari A, Aljamaan F, Alhazzani W, et al. Cytomegalovirus infection in immunocompetent critically ill adults: literature review. Ann Intensive Care. 2016;6:110.
   PubMed Web of Science ®Google Scholar
• De Vlieger G, Meersseman W, Lagrou K, et al. Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients*. Crit Care Med. 2012;40:36–42.
   PubMed Web of Science ®Google Scholar
• Frantzeskaki FG, Karampi E-S, Kottaridi C, et al. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers. J Crit Care. 2015;30:276–281.
   PubMed Web of Science ®Google Scholar
• Heininger A, Haeberle H, Fischer I, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care. 2011;15:R77.
   PubMed Web of Science ®Google Scholar
• Limaye AP, Boeckh M. CMV in critically ill patients: pathogen or bystander? Rev Med Virol. 2010;20:372–379.
   PubMed Web of Science ®Google Scholar
• Jaber S, Chanques G, Borry J, et al. Cytomegalovirus infection in critically Ill patients. Chest. 2005;127:233–241.
   PubMed Web of Science ®Google Scholar
• Ong DSY, Bonten MJM, Spitoni C, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64:1204–1210.
   PubMed Web of Science ®Google Scholar
• Simonnet A, Engelmann I, Moreau A-S, et al. High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19 .Infect Dis Now. 2021; 51: 296–299.
   PubMedGoogle Scholar
• Balc’h P L, Pinceaux K, Pronier C, et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care. 2020;24:530.
   PubMed Web of Science ®Google Scholar
• Cowley NJ, Owen A, Shiels SC, et al. Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically Ill patients: a randomized clinical trial. JAMA Intern Med. 2017;177:774.
   PubMed Web of Science ®Google Scholar
• Limaye AP, Stapleton RD, Peng L, et al. Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: a randomized clinical trial. JAMA. 2017;318:731.
   PubMed Web of Science ®Google Scholar
• Network REVA, Papazian L, Jaber S, et al.; the Preemptive Herpesviridae Treatment Study Group. Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation. Ann Intensive Care. 2021;11:33.
   PubMed Web of Science ®Google Scholar
• Libert N, Bigaillon C, Chargari C, et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J. 2015;38:70.
   PubMed Web of Science ®Google Scholar
• He H, Wang Y, Wu M, et al. Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit: EBV and mortality in ICU. Clin Respir J. 2017;11:895–900.
   PubMed Web of Science ®Google Scholar
• Friedrichs I, Bingold T, Keppler OT, et al. Detection of herpes virus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract? .Med Microbiol Immunol (Berl). Med Microbiol Immunol (Berl). 2013;202:431–436.
   PubMed Web of Science ®Google Scholar
• Tachikawa R, Tomii K, Seo R, et al. Detection of herpes viruses by multiplex and real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with acute lung injury or acute respiratory distress syndrome. Respiration. 2014;87:279–286.
   PubMed Web of Science ®Google Scholar
• Xie Y, Cao S, Dong H, et al. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect Dis. 2021;21:955.
   PubMed Web of Science ®Google Scholar